CRISPR/Cas9-Engineered HLA-Deleted Glomerular Endothelial Cells as a Tool to Predict Pathogenic Non-HLA Antibodies in Kidney Transplant Recipients
利用 CRISPR/Cas9 工程化 HLA 删除的肾小球内皮细胞作为预测肾移植受者致病性非 HLA 抗体的工具
期刊:Journal of the American Society of Nephrology
影响因子:10.3
doi:10.1681/ASN.2021050689
Baptiste Lamarthée, Carole Burger, Charlotte Leclaire, Emilie Lebraud, Aniela Zablocki, Lise Morin, Xavier Lebreton, Béatrice Charreau, Renaud Snanoudj, Soëli Charbonnier, Tifanie Blein, Mélanie Hardy, Julien Zuber, Simon Satchell, Morgan Gallazzini, Fabiola Terzi, Christophe Legendre, Jean Luc Taup
